Journal of Pharmacovigilance

Current Issue

Volume 12, Issue 4, 2024

Commentary Article

Extracting Clinical Insights from Pharmacovigilance Data: Identifying Drug Interactions and Population-Specific Risks

• Julie Simoes*

DOI: 10.35248/2329-6887.24.12.495

Perspective Article

Proactive Drug Safety Surveillance: Enhancing Patient Safety through Pharmacovigilance and Individualized Therapy

• Christin Valenti*

DOI: 10.35248/2329-6887.24.12.496

Opinion Article

Optimizing Neuropsychiatric Medication Safety: Challenges and Advancements in Pharmacovigilance

• Katrien Aleksandrov*

DOI: 10.35248/2329-6887.24.12.497

Commentary Article

Antimicrobial Pharmacovigilance: Resistance, Safety and Clinical Practice

• Sherlock Pissano*

DOI: 10.35248/2329-6887.24.12.498

Review Article

Impact of Switch to Non-Prescription Status on the Safety Profile of Sildenafil and Tadalafil: Assessment of Pharmacovigilance Databases

• Mark Waring and Amritdeep Gill*

DOI: 10.35841/2329-6887.24.12.497

Perspective

Enhancing Patient Safety in Psychotropic Medication Use: Adverse Drug Reactions in Antidepressant and Antipsychotic Therapies

• Giovanna Nora*

DOI: 10.35248/2329-6887.24.12.499

Volume 13, Issue 1, 2025

Short Communication

Vaccine Safety Surveillance in the mRNA Era

• Naveen Beltran*

DOI: 10.35248/2329-6887.25.13.509

Commentary

Biomarkers for Drug-Induced Liver Injury Monitoring

• Leena Morales*

DOI: 10.35248/2329-6887.25.13.500

Commentary

Machine Learning in Risk Stratification of Drug Events

• Kiran Deshmukh*

DOI: 10.35248/2329-6887.25.13.501

Commentary

Integrating EHRs for Proactive Pharmacovigilance

• Rhea Choudhury*

DOI: 10.35248/2329-6887.25.13.502

Opinion Article

Nanomedicine Safety: Challenges in PV Monitoring

• Leena Sarkar*

DOI: 10.35248/2329-6887.25.13.503

Opinion Article

Pharmacovigilance in Gene Therapy Clinical Trials

• Alicia Renfield*

DOI: 10.35248/2329-6887.25.13.504

Opinion Article

Mobile Health Apps for ADR Reporting Compliance

• Lina Verhoeven*

DOI: 10.35248/2329-6887.25.13.505

Perspective

Pharmacogenomics in Adverse Drug Reaction Prediction

• Mervin Callister*

DOI: 10.35248/2329-6887.25.13.506

Perspective

AI-Powered Signal Detection in Pharmacovigilance Databases

• Elina Kessler*

DOI: 10.35248/2329-6887.25.13.507

Perspective

Real-World Evidence in Post-Marketing Drug Surveillance

• Naveen Beltran*

DOI: 10.35248/2329-6887.25.13.508